ProCE Banner Activity

New Findings in Lung Cancer From WCLC 2021: A Focus on Immunotherapy

Clinical Thought
Review some of the notable studies presented at WCLC 2021 related to immunotherapy and more from Shirish Gadgeel, MD.

Released: October 05, 2021

Expiration: October 04, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Helsinn Healthcare SA

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Shirish Gadgeel, MD

Professor
Division of Hematology/Oncology
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan

Shirish M. Gadgeel, MD, has disclosed that he has received consulting fees from AstraZeneca, Blueprint, Boehringer Ingelheim, Bristol-Myers Squibb, Daichii-Sanyko, Janssen, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche/Genentech, and Takeda; fees for non-CME/CE services from Merck Sharp & Dohme and Xcovery; and other financial or material support from AstraZeneca and Roche/Genentech.